About the Authors

Luis Alberto García Rodríguez


Affiliation Centro Español de Investigación Farmacoepidemiológica (CEIFE), Madrid, Spain

Antonio González-Pérez

Affiliations Centro Español de Investigación Farmacoepidemiológica (CEIFE), Madrid, Spain, Departamento de Genómica Estructural, Neocodex SL, Sevilla, Spain

Héctor Bueno

Affiliation Department of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain

John Hwa

Affiliation Section of Cardiovascular Medicine, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America

Competing Interests

I have read the journal's policy and have the following conflicts: CEIFE has received unrestricted research grants from Bayer and Pfizer in the last five years. Dr. Bueno reports having received consulting fees from Almirall, Bayer, BMS, and Sanofi-Aventis, and research grants from Astra-Zeneca, BMS, and Pfizer. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: LAGR AG-P. Performed the experiments: LAGR AG-P. Analyzed the data: LAGR AG-P JH. Wrote the paper: LAGR AG-P JH HB.